Best,
Brendan Stack, MD Vice Chair AHNS Endocrine Section
Greg Randolph, MD Chair AHNS Endocrine Section

1. AHNS.AAO-HNSF Young Investigator Combined Award – Open to fellows and assistant professors. Must be AHNS member (may be candidate member). To support research in neoplastic disease of the head and neck. Up to two years, $20,000 per year. One award available per year.
2. AHNS/AAO-HNSF Translational Innovator Award – Applicants must have completed residency or fellowship training in seven years or less prior to submitting application. Candidates need to have demonstrated the capacity or potential for a highly productive independent research career with an emphasis in head and neck surgical oncology. Two years, non-renewable, $80,000 maximum ($40,000 per year), one available annually.
3. AHNS Pilot Grant – Open to Medical Students, residents, PhD, and Junior Faculty residing in the U.S. or Canada to support basic, translational, or clinical research projects in head and neck oncology. One year, $10,000.00. One award available this year.
4. AHNS Ballantyne Resident Research Pilot Grant – for best grant application by a resident, this award utilizes the same forms and guidelines as the pilot grant (above). One year, non-renewable, $10,000 maximum total costs. One award available per year. The top ranked pilot award will be honored as the Ballantyne Award.
5. AHNS Endocrine Surgery Section Eisai Research Award – Open to medical students focusing in otolaryngology, otolaryngology residents, PhDs or faculty members in otolaryngology departments. Research topics must relate to endocrine surgery or disease. Preference will be given to early-stage investigators (10 years or less from a terminal degree or fellowship training) or more experienced researchers pursuing a new line of inquiry for which pilot data are needed. One year, $10,000.00. One award available this year.
6. AHNS Endocrine Surgery Section Stryker Research Grant – Open to medical students focusing in otolaryngology, otolaryngology residents, PhDs or faculty members in otolaryngology departments. Research topics must relate to endocrine surgery or disease. Preference will be given to early-stage investigators (10 years or less from a terminal degree or fellowship training) or more experienced researchers pursuing a new line of inquiry for which pilot data are needed. One year, $10,000.00. One award available this year.
7. AHNS Presidential Request for Application Pilot Award on Mucosal Head and Neck Cancer Research – Open to all otolaryngology-head and neck surgery residents, fellows, and faculty. Previous AHNS or AAO-HNS Foundation research grant recipients are eligible to compete for this grant. However, candidates who have successfully obtained funding from a private, institutional, or federal funding agency for the same research are ineligible. Candidates who have applied for support of the same research from other funding sources, and who are notified of an award from both another agency and from AHNS must choose only one of the awards. One year, $10,000. One award available.
8. AHNS Presidential Request for Application Pilot Award on Salivary Gland Cancer Research – Open to active AHNS members, or trainees (ACGME-accredited otolaryngology residents or AHNS-accredited head and neck surgery fellows) sponsored by an AHNS member can apply. Previous AHNS or AAO-HNS Foundation research grant recipients are eligible to compete for this grant. However, candidates who have successfully obtained funding from a private, institutional, or federal funding agency for the same research are ineligible. Candidates who have applied for support of the same research from other funding sources, and who are notified of an award from both another agency and from AHNS must choose only one of the awards. One year, $10,000. One award available.
9. AHNS Presidential Request for Application Pilot Award on Basic and Translational Research – This high risk, high reward grant is open to early or mid-career investigators who are AHNS members in good standing. Previous AHNS or AAO-HNS Foundation research grant recipients are eligible to compete for this grant. However, candidates who have successfully obtained funding from a private, institutional, or federal funding agency for the same research are ineligible. Candidates who have applied for support of the same research from other funding sources, and who are notified of an award from both another agency and from AHNS must choose only one of the awards. One year, $10,000. One award available.

Best,
Brendan Stack, MD Vice Chair AHNS Endocrine Section
Greg Randolph, MD Chair AHNS Endocrine Section

Management of Salivary Malignancy

Instructional Course: Management of Salivary Malignancy Case Based Panel Discussion

Date: Wednesday, December 9, 2020

Time: 4:00 PM Pacific /6:00 PM Central / 7:00 PM Eastern
Session is an hour long

Complimentary to all attendees

Register Here

Learning Objective:

At the conclusion of this webinar, participants will be able to:

1. Recognize common areas of controversy in the management of salivary malignancy
2. Prioritize therapeutic options for salivary malignancy that maximizes benefit and minimizes harm
3. Plan appropriate reconstruction after ablative surgery for salivary malignancy

Faculty:

Moderator: David Cognetti, MD, Thomas Jefferson University

Panelists:
Cecelia Schmalbach, MD MSc FACS, Temple University
Kiran Kakarala, MD, University of Kansas
William Ryan, MD, University of California, San Francisco

Management of Salivary Malignancy

Instructional Course: Management of Salivary Malignancy Case Based Panel Discussion

Date: Wednesday, December 9, 2020

Time: 4:00 PM Pacific /6:00 PM Central / 7:00 PM Eastern
Session is an hour long

Complimentary to all attendees

Register Here

Learning Objective:

At the conclusion of this webinar, participants will be able to:

1. Recognize common areas of controversy in the management of salivary malignancy
2. Prioritize therapeutic options for salivary malignancy that maximizes benefit and minimizes harm
3. Plan appropriate reconstruction after ablative surgery for salivary malignancy

Faculty:

Moderator: David Cognetti, MD, Thomas Jefferson University

Panelists:
Cecelia Schmalbach, MD MSc FACS, Temple University
Kiran Kakarala, MD, University of Kansas
William Ryan, MD, University of California, San Francisco